Skip to Content

Representative Settlements

Neurontin Antitrust Litigation

Status:Settled
Practice Area(s): Antitrust
Berger & Montague obtained a $190 million settlement on behalf of a class of direct purchasers of the brand-name prescription drug Neurontin. The Neurontin class alleged that Pfizer, Inc., one of the nation's largest pharmaceutical...

Nifedipine Antitrust Litigation

Status:Settled
Practice Area(s): Antitrust
Berger & Montague represented a class of purchasers of generic Adalat CC 30 mg and 60 mg, generic versions of the blood pressure medicine Adalat CC. Defendants Biovail Corporation (in conjunction with its partner, Teva Pharmaceuticals USA, Inc.)...

Norvir Antitrust Litigation

Status:Settled
Practice Area(s): Antitrust
Berger & Montague obtained a $52 million settlement for a class of direct purchasers of the anti-AIDS medicines Norvir and Kaletra. Norvir serves as a "booster" to prolong the efficacy of other anti-AIDS drugs. Berger & Montague, as co-lead...

Ovcon 35 Direct Purchaser Antitrust Litigation

Status:Settled
Settlement Amount: $22 million
Practice Area(s): Antitrust
Berger & Montague was among the lead class counsel in this antitrust class action on behalf of direct purchasers of the oral birth control medication, Ovcon 35. The class accused the defendants Warner Chilcott and Barr Pharmaceuticals of entering...

OxyContin Antitrust Litigation

Status:Settled
Settlement Amount: $16 million
Practice Area(s): Antitrust
Plaintiffs, represented by Berger & Montague, alleged that Defendant Purdue Pharmaceuticals filed bogus patent prosecution actions in an effort to crush competition from generic competitors.

Platinol Antitrust Litigation

Status:Settled
Settlement Amount: $50 million
Practice Area(s): Antitrust
North Shore Hematology/Oncology Associates brought this antitrust class action on behalf of itself and a class of direct purchasers of the cancer drug Platinol. Platinol is the brand-name version of the generic drug cisplatin. North Shore Hematology...

Prandin Antitrust Litigation

Status:Settled
Practice Area(s): Antitrust
Plaintiffs alleged that defendants Novo Nordisk A/S and Novo Nordisk, Inc. blocked market entry of generic versions of Prandin that would have competed with Defendants' more expensive, branded version of Prandin, by manipulating the FDA's Orange Book...

Puerto Rico Cabotage Antitrust Litigation

Status:Settled
Settlement Amount: $52.25 million
Practice Area(s): Antitrust
Berger & Montague served as a court-appointed member of the Plaintiffs' Steering Committee in this case brought on behalf of a proposed class of direct purchasers of ocean shipping services between the United States and Puerto Rico, from the period...

Red Eagle Resources Corp., Inc. v. Baker Hughes, Inc.

Status:Settled
Settlement Amount: $52.5 million
Practice Area(s): Antitrust
The firm was a member of the plaintiffs' executive committee in this antitrust class action over drill bits which yielded a settlement of $52.5 million.

Relafen Antitrust Litigation

Status:Settled
Settlement Amount: $175 million
Practice Area(s): Antitrust
Berger & Montague was one of a small group of firms who prepared for the trial of this nationwide class action against GlaxoSmithKline, which was alleged to have used fraudulently-procured patents to block competitors from marketing less-expensive...

Remeron Antitrust Litigation

Status:Settled
Settlement Amount: $75 million
Practice Area(s): Antitrust
Berger & Montague was one of a small group of firms alleging that the manufacturer of this drug was paying its competitors to refrain from introducing less expensive generic versions of Remeron.

Rochester Drug Co-Operative, Inc. v. Braintree Laboratories, Inc.

Status:Settled
Settlement Amount: $17.25 million
Practice Area(s): Antitrust
Berger and Montague served as co-lead counsel representing a certified class of direct purchasers of the drug Miralax. Plaintiffs alleged that Braintree Laboratories, Inc. unlawfully acquired and maintained monopoly power over a prescription drug known...

Ross v. American Express Co.

Status:Settled
Practice Area(s): Antitrust
Berger & Montague represented cardholders in a related case to In re Currency Conversion Fee Antitrust Litigation ("CCF I"), MDL No. 1409, Master File No. M21-95 (S.D.N.Y.) (Pauley, J.), in the same court. The lawsuit concerned the fees that...

Ross v. Bank of America

Status:Settled
Practice Area(s): Antitrust
The lawsuit alleges that six major credit card banks, and one arbitration provider, unlawfully colluded to require cardholders to arbitrate disputes, including debt collections, and to preclude cardholders from participating in any class actions. ...

Terazosin Hydrochloride Antitrust Litigation

Status:Settled
Settlement Amount: $74 million
Practice Area(s): Antitrust
Berger & Montague served as a member of the Executive Committee representing a class of direct purchasers of the brand-name drug Hytrin, a prescription drug used to treat hypertension. Plaintiffs alleged that Abbott entered into separate agreements...

Tricor Antitrust Litigation

Status:Settled
Settlement Amount: $250 million
Practice Area(s): Antitrust
Berger & Montague represented a Class of pharmaceutical wholesalers and pharmacies, charging Abbott Laboratories and Fournier Industrie et Sante, two brand-name pharmaceutical companies, with monopolizing the market for the cholesterol drug Tricor...
Go to page: 1 2